Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.6%

2 terminated/withdrawn out of 36 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

8%

3 trials in Phase 3/4

Results Transparency

40%

12 of 30 completed trials have results

Key Signals

3 recruiting12 with results

Enrollment Performance

Analytics

N/A
19(59.4%)
Phase 2
5(15.6%)
Phase 1
4(12.5%)
Phase 3
3(9.4%)
Early Phase 1
1(3.1%)
32Total
N/A(19)
Phase 2(5)
Phase 1(4)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (36)

Showing 20 of 36 trials
NCT04060030Phase 2Recruiting

Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism

Role: collaborator

NCT06059352Recruiting

Sleep and Central Auditory Processing Disorder in Autism Spectrum Disorder

Role: collaborator

NCT05928247Not ApplicableRecruiting

Manualized Assessment and Treatment Model of Challenging Behavior

Role: collaborator

NCT04381195Completed

Relationships, Employment, Autonomy, and Life Satisfaction (REALS) Study

Role: collaborator

NCT06038799Not ApplicableTerminated

Caregiver Skills Training: Comparing Clinician Training Methods

Role: collaborator

NCT04259671Not ApplicableCompleted

Exploring the Efficacy and Usability of the My Autism Passport (MAP).

Role: collaborator

NCT01013545Not ApplicableCompleted

Developmental and Augmented Intervention for Facilitating Expressive Language

Role: lead

NCT05822921Not ApplicableCompleted

Providing Accessible Diagnostic Evaluations and Psychoeducation for Autism Spectrum Disorder in Rural Southwest Virginia

Role: collaborator

NCT03899831Not ApplicableCompleted

Structured Function-Based Elopement Treatment Program

Role: collaborator

NCT01250938Not ApplicableCompleted

Effectiveness of Early Intervention in an Underserved Population

Role: collaborator

NCT02552147Phase 1Completed

Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism

Role: collaborator

NCT01179841Not ApplicableCompleted

Intervention for Toddlers at Risk for Autism Spectrum Disorders (ASD)

Role: collaborator

NCT01425918Not ApplicableCompleted

Social Cognitive Development in Young Children With Autism

Role: collaborator

NCT01813318Phase 1Completed

Study of Acamprosate in Autism

Role: collaborator

NCT02792894Not ApplicableCompleted

Family Networks (FaNs) for Children With Developmental Disorders and Delays

Role: collaborator

NCT00902798Not ApplicableCompleted

Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder

Role: collaborator

NCT02903030Early Phase 1Completed

Probiotics for Quality of Life in Autism Spectrum Disorders

Role: collaborator

NCT01881750Not ApplicableCompleted

Pivotal Response Group Treatment for Parents of Young Children With Autism

Role: collaborator

NCT02088905Not ApplicableCompleted

Efficacy of Parent-Child Interaction Therapy With Autism Spectrum Disorder

Role: collaborator

NCT01302964Phase 3Completed

Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders

Role: collaborator